ONVO
Price
$2.04
Change
+$0.03 (+1.49%)
Updated
Apr 23 closing price
Capitalization
3.62M
28 days until earnings call
ORMP
Price
$2.31
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
93.96M
33 days until earnings call
Ad is loading...

ONVO vs ORMP

Header iconONVO vs ORMP Comparison
Open Charts ONVO vs ORMPBanner chart's image
Organovo Holdings
Price$2.04
Change+$0.03 (+1.49%)
Volume$244.95K
Capitalization3.62M
Oramed Pharmaceuticals
Price$2.31
Change-$0.00 (-0.00%)
Volume$100
Capitalization93.96M
ONVO vs ORMP Comparison Chart
Loading...
ONVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONVO vs. ORMP commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONVO is a Buy and ORMP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ONVO: $2.02 vs. ORMP: $2.31)
Brand notoriety: ONVO and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONVO: 24% vs. ORMP: 12%
Market capitalization -- ONVO: $3.62M vs. ORMP: $93.55M
ONVO [@Biotechnology] is valued at $3.62M. ORMP’s [@Biotechnology] market capitalization is $93.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONVO’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • ONVO’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than ONVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONVO’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • ONVO’s TA Score: 5 bullish, 3 bearish.
  • ORMP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ONVO and ORMP are a good buy in the short-term.

Price Growth

ONVO (@Biotechnology) experienced а +21.69% price change this week, while ORMP (@Biotechnology) price change was +4.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

ONVO is expected to report earnings on May 22, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($94M) has a higher market cap than ONVO($3.62M). ORMP YTD gains are higher at: -4.959 vs. ONVO (-63.398). ORMP has higher annual earnings (EBITDA): 9.44M vs. ONVO (-12.52M). ORMP has more cash in the bank: 142M vs. ONVO (753). ORMP has less debt than ONVO: ORMP (429K) vs ONVO (1.06M). ONVO has higher revenues than ORMP: ONVO (122K) vs ORMP (0).
ONVOORMPONVO / ORMP
Capitalization3.62M94M4%
EBITDA-12.52M9.44M-133%
Gain YTD-63.398-4.9591,279%
P/E RatioN/A20.91-
Revenue122K0-
Total Cash753142M0%
Total Debt1.06M429K247%
FUNDAMENTALS RATINGS
ONVO vs ORMP: Fundamental Ratings
ONVO
ORMP
OUTLOOK RATING
1..100
2511
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9880
PRICE GROWTH RATING
1..100
9670
P/E GROWTH RATING
1..100
10040
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (67) in the Pharmaceuticals Other industry is in the same range as ONVO (68) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ONVO’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ONVO (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ONVO’s over the last 12 months.

ORMP's SMR Rating (80) in the Pharmaceuticals Other industry is in the same range as ONVO (98) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ONVO’s over the last 12 months.

ORMP's Price Growth Rating (70) in the Pharmaceuticals Other industry is in the same range as ONVO (96) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ONVO’s over the last 12 months.

ORMP's P/E Growth Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for ONVO (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than ONVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ONVOORMP
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ONVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WYNN79.112.14
+2.78%
Wynn Resorts Limited
PALI0.710.02
+2.71%
Palisade Bio
BATRK38.910.22
+0.57%
Atlanta Braves Holdings
WHG16.59-0.11
-0.66%
Westwood Holdings Group
PBT9.90-0.10
-1.00%
Permian Basin Royalty Trust

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-0.43%
BTAI - ORMP
44%
Loosely correlated
+9.47%
INO - ORMP
44%
Loosely correlated
+2.67%
MBIO - ORMP
44%
Loosely correlated
-6.72%
VERV - ORMP
44%
Loosely correlated
+5.67%
ZNTL - ORMP
43%
Loosely correlated
+0.67%
More